# Ernexa Therapeutics Inc.: Form S-1, filed May 27, 2021

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: S-1
- Filed: 2021-05-27
- Accepted by EDGAR: May 27, 2021, 17:20 ET
- Period: not reported
- Accession: 0001140361-21-019087
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000114036121019087/nt10023650x4_s1.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000114036121019087/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000114036121019087/nt10023650x4_s1.htm

Filed May 27, 2021.
Source: SEC EDGAR, the filing index for accession 0001140361-21-019087. Last ingested by Listed: Nov 11, 2026, 02:49 ET. No prices; not investment advice.